Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+ [Response to Letter]

IF 2.9 3区医学 Q2 INFECTIOUS DISEASES

Infection and Drug Resistance Pub Date : 2024-07-19 DOI:10.2147/idr.s486223

Mateusz Szymański, Małgorzata M Skiba, Małgorzata Piasecka

引用次数: 0

Abstract

Response to Letter in regards to Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+ [Letter]

查看原文本刊更多论文

头孢唑肟-阿维巴坦与阿兹曲南对碳青霉烯酶阳性肺炎克雷伯菌 MBL+、NDM+ 的协同作用 [回信］

对 "头孢唑肟-阿维菌素与阿兹曲南对碳青霉烯酶阳性肺炎克雷伯菌 MBL+、NDM+ 的协同作用 "信件的回复[信件］

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infection and Drug Resistance Medicine-Pharmacology (medical)

CiteScore

5.60

自引率

7.70%

发文量

826

审稿时长

16 weeks

期刊介绍： About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.

文献相关原料

公司名称	产品信息	采购帮参考价格